Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
Open Access
- 5 August 2008
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (5) , 768-773
Abstract
This study identifies the genetic fingerprint of poorly differentiated endometrioid endometrial carcinomas (G3-EEC) and analyses the potential utility of trefoil factor 3 (TFF3) as novel serum marker in G3-EEC. Affymetrix microarrays were used to identify the gene expression patterns of 19 snap-frozen G3-EEC and 15 normal endometrium (NE) biopsies. Quantitative real-time PCR (qRT-PCR) and immunohistochemistry were used to validate TFF3 expression. Finally, TFF3 serum levels were determined by ELISA in 25 G3-EEC patients, 42 healthy controls, and in 13 endometrial hyperplasia patients. Hierarchical cluster analysis showed TFF3 as the top differentially expressed gene between 363 upregulated genes in G3-EEC, when compared with NE. Trefoil factor 3 gene expression levels analysed by qRT-PCR significantly correlated with Affymetrix results (PPPP=0.012). In conclusion, TFF3 is highly expressed at gene and protein level in G3-EEC. Further investigations on a wider set of samples are warranted to validate TFF3 as a novel serum marker for early detection and/or monitoring of G3-EEC patients.Keywords
This publication has 33 references indexed in Scilit:
- Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapyGynecologic Oncology, 2006
- Trefoil factor 3 is overexpressed in human prostate cancerThe Prostate, 2004
- Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase‐2 and EGF receptor signalingThe FASEB Journal, 2003
- Characterization of Gene Expression Profiles in Intraductal Papillary-Mucinous Tumors of the PancreasThe American Journal of Pathology, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Induction of scattering and cellular invasion by trefoil peptides in src‐ and RhoA‐transformed kidney and colonic epithelial cellsThe FASEB Journal, 2001
- Determination of a Normal Level of Serum CA125 in Postmenopausal Women as a Tool for Preoperative Evaluation and Postoperative Surveillance of Endometrial CarcinomaGynecologic Oncology, 1998
- Value of Preoperative CA 125 Level in the Management of Uterine Cancer and Prediction of Clinical OutcomeObstetrics & Gynecology, 1997
- A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancerBreast Cancer Research and Treatment, 1996
- Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.Journal of Clinical Investigation, 1994